London, England, United Kingdom CD Capital is the famous VC, which was founded in 2013. The venture was found in Asia in China. The main department of described VC is located in the Shanghai.
The overall number of key employees were 4.
Among the most successful fund investment fields, there are Biopharma, Information Technology. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight Creative Biosciences, Singlera Genomics, CMAB BioPharm. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the CD Capital, startups are often financed by ZhenFund, Qianhai Fund of Funds, SBCVC. The meaningful sponsors for the fund in investment in the same round are SBCVC, Qianhai Fund of Funds, Hillhouse Capital Group. In the next rounds fund is usually obtained by Zero2IPO Capital, SBCVC, Zhongjin Qichen.
Speaking about the real fund results, this VC is 24 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The high activity for fund was in 2019.
Related Funds
| Fund Name | Location |
| Castle Island Ventures | Cambridge, Massachusetts, United States |
| Chongshan Capital | China, Guangdong, Jiangxi |
| CR Capital Management | Beijing, Beijing, China |
| DS Investment Management Co.,Ltd | Seoul, Seoul-t'ukpyolsi, South Korea |
| Egis Technology | Taipei, Taiwan |
| eGuardian | Central Region, Singapore, Singapore |
| Gaea Technology | China, Guangdong, Shenzhen |
| Green Shield Canada | Canada, Ontario, Windsor |
| Grosvenor Capital Management | Chicago, Illinois, United States |
| Investment Partners | Metuchen, New Jersey, United States |
| Keller Enterprises | Charlottesville, United States, Virginia |
| Lapam Capital | Beijing, Beijing, China |
| Louisiana Technology Innovation Fund | Baton Rouge, Louisiana, United States |
| MSouth Equity Partners | Atlanta, Georgia, United States |
| Northeast Securities | New York, New York, United States |
| Orchestra Medical Ventures | New York, New York, United States |
| Oryzn Capital | Israel, Tel Aviv, Tel Aviv |
| WuXi Biologics | Anhui, China, Wuxi |
| Yadu Corporation | Delhi, India, New Delhi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Xunshi Technology | $15M | 29 Oct 2019 | Hangzhou, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Xunshi Technology | $15M | 29 Oct 2019 | Hangzhou, Zhejiang, China |
